<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/261002-process-for-production-of-alpha-anomer-of-ribofuranosyl-sulfonate-and-production-of-nucleoside-from-the-alpha-anomer-so-produced by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:42:56 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 261002:PROCESS FOR PRODUCTION OF ALPHA-ANOMER OF RIBOFURANOSYL SULFONATE, AND PRODUCTION OF NUCLEOSIDE FROM THE ALPHA-ANOMER, SO PRODUCED</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PROCESS FOR PRODUCTION OF ALPHA-ANOMER OF RIBOFURANOSYL SULFONATE, AND PRODUCTION OF NUCLEOSIDE FROM THE ALPHA-ANOMER, SO PRODUCED</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A process of preparing an alpha-anomer enriched 2- deoxy-2, 2-difluoro-D-ribofunanosyl sulfonate, which is useful as an intermediate in the preparation of a beta nucleoside, such as gemcitabine, an anti-tumor agent. A beta-2-deoxy-2,2-difluoro-D-ribofunanosyl sulfonate is heated and converted to an alpha-2-deoxy-2, 2-difluoro-D- ribofunanosyl sulfonate in the absence of an effective amount of a sulfonate salt to facilitate the conversion. In addition, an anomeric mixture of an alpha-anomer and a beta-anomer of 2-deoxy-2, 2-difluoro-D-ribofunanosyl sulfonate can be dissolved in a mixture of water and a solvent and heated to produce a lactol, which may be further converted to jan alpha-anomer enriched 2-deoxy- 2, 2-difluoro-D-ribofunanosyl sulfonate.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td>PROCESS OF MAKING AN ALPHA-ANOMER ENRICHED 2-DEOXY-<br>
2, 2-DIFLOURO-D-RIBOFURANOSYL SULFONATE AND USE<br>
THEREOF FOR MAKING A BETA NUCLEOSIDE<br>
RELATED APPLICATIONS<br>
[0001] This application claims priority from U.S.<br>
Provisional Patent Application Serial Number 60/687,593<br>
which was filed on June 3, 2005.<br>
BACKGROUND OF THE INVENTION<br>
1.	Field of the Invention<br>
[0002] The present invention pertains to a process of<br>
preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-<br>
ribofunanosyl sulfonates, which are useful as<br>
intermediates in the preparation of beta nucleosides,<br>
which are anti-tumor agents. Specifically, the present<br>
invention pertains to a process of converting beta-2-<br>
deoxy-2,2-difluoro-D-ribofunanosyl sulfonates to alpha-<br>
2-deoxy-2,2-difluoro-D-ribofunanosyl sulfonates, which<br>
may be further converted to desired beta nucleosides.<br>
2.	Description of the Related Art<br>
[0003] Stereoselective process for preparing a<br>
nucleoside involves stereochemical inversion of a<br>
furanose sugar at the anomeric position, therefore when<br>
beta-nucleoside is the desired product, an appropriate<br>
sugar intermediate enriched in alpha anomer is<br>
preferably used as the substrate in the glycosylatipn<br>
reaction. For example, the known substance,<br>
gemcitabine, is a nucleoside in the β-configuration and,<br>
therefore, it may preferably be prepared by inversion of<br>
the center resulting from SN2 displacement of a blocked<br><br>
2<br>
cytosine on the appropriate sugar sulfonate intermediate<br>
in the α-configuration.<br>
[0004] Currently known technology results in the<br>
preparation of alpha-anomer enriched sulfonate esters by<br>
the reaction of a blocked sugar lactol with a<br>
sulfonating reagent at low temperatures. The desired<br>
alpha-anomer can be crystallized in enhanced purity but<br>
in low yield. The remaining material is usually a<br>
mixture of alpha and beta anomers from which enriched,<br>
alpha-anomer can not easily be isolated. Without an<br>
effective method of recovering this material and<br>
converting it to the desired alpha enhanced anomer, the<br>
yield of alpha anomer is low, and the commercial<br>
viability of the process is in jeopardy.<br>
[0005] U.S. Patent No. 5,256,798 discloses a process<br>
of preparing an alpha-anomer enriched ribofuranosyl<br>
sulfonate by treating a beta-anomer ribofuranosyl<br>
sulfonate with a source of conjugate anion of a sulfonic<br>
acid (i.e., sulfonate salt) at an elevated temperature<br>
in an inert organic solvent. However the difficulty of<br>
solubilizing the conjugate anion of sulfonic acid in a<br>
solvent and the necessity of removal of the solvent and<br>
aqueous workup limit the usefulness of this procedure.<br>
Therefore there is still a need for a more efficient<br>
procedure.<br><br>
3<br>
SUMMARY OF THE INVENTION<br>
[0006] The present invention provides a process for<br>
producing an alpha-anomer enriched ribofunanosyl<br>
methanesulfonates of formula (I)<br><br>
comprising heating a beta-anomer of the formula<br>
(II)<br><br>
II<br>
to convert the beta-anomer to the alpha-anomer in<br>
the absence of an effective amount of a sulfonate<br>
salt to facilitate the conversion of the beta-<br>
anomer to the alpha-anomer; wherein each Y is<br>
independently selected from hydroxyl protecting<br>
groups, and R is an alkyl, substituted alkyl, aryl,<br>
or a substituted aryl group.<br><br>
4<br>
[0007] In addition, the present invention provides a<br>
process of making a lactol of formula (III)<br><br>
III<br>
comprising the steps of<br>
a)	dissolving a mixture of an alpha-anomer of<br>
formula (I) and a beta-anomer of formula (II) in<br>
a mixture of an organic solvent, preferably a<br>
polar organic solvent, and water;<br>
b)	heating the mixture at an elevated temperature<br>
to cause the reaction of solvolysis; and<br>
c)	diluting the mixture with water and extracting<br>
the lactol of Formula (III) with an organic<br>
solvent.<br>
[0008] The lactol of formula III can be converted to<br>
a ribofunanosyl sulfonate, preferably enriched in alpha-<br>
anomer of formula (I) , by reacting with a sulfonating<br>
reagent.<br>
[0009] The alpha-anomer of formula I can be caused to<br>
react with a nucleobase derivative to prepare a beta-<br>
anomer enriched nucleoside of the formula (IV)<br><br>
5<br><br>
wherein R' is a nucleobase.<br>
[0010] These and other features, aspects, and<br>
advantages of the present invention will become better<br>
understood with reference to the following description<br>
and appended claims.<br>
DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED<br>
EMBODIMENTS<br>
[0011] As used herein, the term "alpha/beta mixtures"<br>
refers to sulfonate esters of 2-deoxy-2,2-difluoro-D-<br>
ribofuranose of formula (I) and (II). It is expressed as<br>
a weight/weight ratio or as a percent.<br>
[0012] The term "epimerization" refers to the<br>
isomerization of the sulfonate esters of formula (I) and<br>
(II).<br>
[0013] The term "lactol" refers to 2-deoxy-2,2-<br>
difluoro-D-ribofuranose of formula (III).<br>
[0014] The term "alpha-enriched" or "alpha-enhanced"<br>
mixture refers to a mixture with a ratio of alpha and<br>
beta anomers greater than 1:1 and includes a<br>
substantially pure alpha anomer.<br>
[0015] The term "hydrolysis" or "solvolysis" refers<br>
to the replacement of the sulfonate ester by an hydroxyl<br>
group to form the lactol.<br><br>
6<br>
[0016] The term "thermal isomerization" refers to the<br>
heating of the alpha/beta mixture to convert the beta<br>
anomer to the alpha anomer without the addition of a<br>
sulfonate salt to facilitate the conversion of the beta-<br>
anomer to the alpha-anomer.<br>
[0017] The term "alkyl", refers to a straight,<br>
cyclic, or branched chain aliphatic hydrocarbon group.<br>
[0018] The term "lower alkyl" refers to an alkyl<br>
group which contains up to seven carbon atoms such as<br>
methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, n-<br>
pentyl, n-hexyl, or 3-methylpentyl.<br>
[0019] The term "aryl" refers to a carbocyclic or<br>
heterocyclic group, such as phenyl, naphythyl, or<br>
thienyl.<br>
[0020] The term "lower aryl" refers to an aryl group<br>
which contains from 6 to 12 carbon atoms such as phenyl,<br>
substituted phenyl, naphthyl, etc.<br>
[0021] R in the alpha-anomer formula (I) and beta-<br>
anomer (II) is preferably a lower alkyl or aryl group.<br>
[0022] The term "substituted" refers to the<br>
replacement of hydrogen or a common moiety by one or<br>
more of the groups such as cyano, halo, carboalkoxy,<br>
aryl, nitro, alkoxy, alkyl, and dialkylamino.<br>
[0023] The nucleobase (R') employed herein are<br>
commonly known to organic chemists and no discussion of<br>
their synthesis is necessary. However, in order to be<br>
useful in the present glycosylation process, nucleoside<br>
derivatives or their tautomeric equivalents bearing<br>
amino or hydroxyl groups preferably contain protecting<br>
groups, such as primary amino protecting groups (W)<br>
and/or hydroxyl protecting groups (Z), depending on the<br>
nature of the nucleobase derivative selected. The<br><br>
7<br>
protecting groups block the hydroxyl or amino groups<br>
which may provide competing reaction sites for the beta-<br>
or alpha-anomer carbohydrates. The protecting groups are<br>
attached to the nucleobase (R'), which is reacted with<br>
the alpha-anomer enriched carbohydrate of formulas (I),<br>
and are removed subsequent thereto. A procedure for<br>
protecting nucleobase derivatives is described in U.S.<br>
Pat. No. 4,526,988, the entire content of which is<br>
incorporated herein as reference. Likewise, organic<br>
chemists can readily select a suitable nucleobase<br>
derivative for linking the desired nucleobase (R') to an<br>
alpha or beta carbohydrate of formula (I) or (II) . For<br>
example, U.S. Patent Nos. 5,426,183 and 4,526,988<br>
disclose a number of nucleobases and nucleobase<br>
derivatives. The entire content of U.S. Patent Nos.<br>
5,426,183 and 4,526,988 is incorporated herein as<br>
reference.<br>
[0024] For example, nucleobases without protecting<br>
groups include the following:<br><br>
8<br><br>
wherein R1 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof; and R2 is<br>
selected from the group consisting of hydrogen, alkyl,<br>
halo, and derivatives thereof.<br>
[0025] . Protected nucleobases include, e.g., the<br>
following:<br><br>
9<br><br>
[0026] wherein Z is a hydroxyl protecting group; W is an<br>
amino protecting group; R1 is selected from the group<br>
consisting of hydrogen, alkyl, halo, and derivatives<br>
thereof; and R2 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof.<br>
[0027] The suitable nucleobase derivatives include,<br>
e.g., the following:<br><br>
10<br><br>
wherein Z is a hydroxyl protecting group; W is an amino<br>
protecting group; R1 is selected from the group<br>
consisting of hydrogen, alkyl, halo, and derivatives<br>
thereof; and R2 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof.<br>
[0028] The term "sulfonate salt" refers to a source<br>
of conjugate anion of a sulfonic acid, as explained in<br>
U.S. Patent No. 5,256,798, the entire content of which<br>
is incorporated herein as reference.<br>
[0029] The term "sulfonating reagent" refers to an<br>
reagent that can react with the lactol of formula (III)<br>
to prepare a sulfonate ester of 2-deoxy-2,2-difluoro-D-<br>
ribofuranose of formula (I) or (II) . Suitable<br>
sulfonating reagents may be selected from the group<br>
consisting of arylsulfonyl halides, substituted<br>
arylsulfonyl halides, arylsulfonyl anhydrides and<br><br>
11<br>
substituted arylsulfonyl anhydrides. Substituted<br>
arylsulfonyl halides are selected from the group<br>
consisting of 2-nitrobenzenesulfonyl chloride, p-<br>
cyanobenzenesulfonyl 3-nitrobenzenesulfonyl chloride,<br>
2, 4-dinitrobenzenesulfonyl chloride, p-<br>
bromobenzenesulfonyl chloride, p-fluorobenzenesulfonyl<br>
chloride, 2,4,6-triisopropylbenzenesulfonyl chloride,<br>
2,4,6-trimethylbenzenesulfonyl chloride, p-<br>
iodobenzenesulfonyl chloride, p-chlorobenzenesulfonyl.<br>
chloride, p-methoxybenzenesulfonyl chloride, and p-<br>
toluenesulfonyl chloride; preferred are 2-<br>
nitrobenzenesulfonyl chloride, 3-nitrobenzenesulfonyl<br>
chloride, p-bromobenzenesulfonyl chloride, p-<br>
fluorobenzenesulfonyl chloride, and p-<br>
chlorobenzenesulfonyl chloride; most preferred is p-<br>
bromobenzenesulfonyl chloride. Preferred arylsulfonyl<br>
anhydrides are selected from benzene sulfonic acid<br>
anhydride and p-bromobenzenesulfonic acid anhydride.<br>
Preferred arylsulfonyl halides are selected from<br>
benzenesulfonyl chloride and 2-naphthylenesulfonyl<br>
chloride; more preferred is benzenesulfonyl chloride.<br>
[0030] The term "hydroxyl protecting group" (Y and<br>
Z) , as used herein, refers to a labile chemical moiety<br>
to protect a hydroxyl group against undesired reactions<br>
during synthetic procedures. After said synthetic<br>
procedure(s) the hydroxyl protecting group as described<br>
herein may be selectively removed. The hydroxyl<br>
protecting groups are known in the art and are described<br>
in Chapter 3 of Protective Groups in Organic Chemistry,<br>
McOmie Ed., Plenum Press, New York (1973), and Chapter 2<br>
of Protective Groups in Organic Synthesis, Green, John,<br>
J. Wiley and Sons, New York (1981); the entire content<br><br>
12<br>
of both of these references is incorporated herein as<br>
reference. Preferred hydroxyl protecting groups are<br>
ester forming groups such as formyl, acetyl, substituted<br>
acetyl, propionyl, butynyl, pivaloyl, 2-chloroacetyl,<br>
benzoyl, substituted benzoyl, phenoxy-carbonyl,<br>
methoxyacetyl; carbonate derivatives such as<br>
phenoxycarbonyl, t-butoxccarbonyl ethoxycarbonyl,<br>
vinyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl and<br>
benzyloxycarbonyl; alkyl ether forming groups such as<br>
benzyl, diphenylmethyl, triphenylmethyl, t-butyl,<br>
methoxy-methyl, tetrahydropyranyl, allyl,<br>
tetrahydrothienyl, 2-methoxyethoxy methyl; and silyl<br>
ether forming groups such as trialkylsilyl,<br>
trimethylsilyl, isopropyldialkylsilyl,<br>
alkyldiisopropylsilyl, triisopropylsilyl, t-<br>
butyldialkyl-silyl and 1,1,3,3,-<br>
tetraisopropyldisloxanyl; carbamates such as N-<br>
phenylcarbamate an d N-imidazoylcarbamate; however more<br>
preferred are benzoyl, mono-substituted benzoyl and<br>
disubstituted benzoyl, acetyl, pivaloyl, triphenylmethyl<br>
ethers, and silyl ether forming groups, especially t-<br>
butyldimethylsilyl; while most preferred is benzoyl.<br>
[0031] The term "amino protecting group" (W) , as used<br>
herein, refers to a labile chemical moiety to protect an<br>
amino group against undesired reactions during synthetic<br>
procedures. After said synthetic procedure(s) the amino<br>
protecting group as described herein may be selectively<br>
removed. Amino protecting groups as known in the art are<br>
described generally in T. K. Greene and P. G. M. Wuts,<br>
Protective Groups in Organic Synthesis, 3rd edition,<br>
John Wiley &amp; Sons, New York (1999) , the entire content<br>
of which is incorporated herein as reference. Examples<br><br>
13<br>
of amino protecting groups include, but are not limited<br>
to, silyl ether forming groups such as trialkylsilyl,<br>
t-butyldialkylsilyl and t-butyldiarylsilyl; carbamates<br>
such as t-butoxycarbonyl, benzyloxycarbonyl, 4-<br>
methoxybenzyloxycarbonyl, 9-fluorenylmethoxycarbonyl ,<br>
and 4-nitrobenzyloxycarbonyl; formyl, acetyl, benzoyl<br>
and pivalamido; ether forming groups such as<br>
methoxymethyl, t-butyl, benzyl, allyl and<br>
tetrahydropyranyl; alkylcarboxamides,<br>
haloalkylcarboxamides, and arylcarboxamides such as 2-<br>
trialkylsilylethoxymethyl, 4-methoxybenzyl, 3,4-<br>
dimethoxybenzyl, t-butyl, phthalamido,<br>
tetrahydropyranyl, tetrahydrofuranyl, methoxymethyl<br>
ether, methoxythiomethyl, trityl, pivalamido, t-<br>
butyldimethylsilyl, t-hexyldimethylsilyl,<br>
triisopropylsilyl, trichloroethoxycarbonyl,<br>
trifluoroacetyl, naphthoyl, formyl, acetyl; sulfonamides<br>
such as alkylsulfonamido and arylsulfonamido.<br>
[0032] The term, "halo" refers to fluoro, chloro,<br>
bromo, and iodo.<br>
[0033] The term "polar inert solvent", as used<br>
herein, refers to a polar solvent which is inert to the<br>
reaction conditions. Examples of polar inert solvents<br>
include amides, sulfoxides, nitriles, and ethers, more<br>
specifically, dimethylsulfoxide, acetonitrile, glyme,<br>
diglyme, tetrahydrofuran, dioxane, pyridine, N-<br>
methylpyrrolidinone, N,N-dimethylformamide, 1,3-<br>
dimethyl-2-imidazolona, N,N-dimethylacetamide, and<br>
mixtures thereof; most preferred- is N,N-<br>
dimethylformamide .<br><br>
14<br>
[0034] The choice of solvent should allow for some<br>
water solubility to carry out the hydrolysis reaction of<br>
making the lactol of Formula (III) .<br>
[0035] The glycosylation reaction between the alpha-<br>
anomer of. formula (I) and the nucleobase derivative can<br>
be carried out by any suitable method, e.g., the method<br>
disclosed in U.S. Patent No. 5,606,048, the entire<br>
content of which is herein incorporated as reference.<br>
For example, the glycosylation reaction may be carried<br>
out at a temperature ranging from about 50 °C to about<br>
100 °C, in an inert solvent such as aromatic, haloalkyl,<br>
alkoxyl-and halo substitute aromatic solvents.<br>
Preferably the inert solvent is a polar inert solvent.<br>
[0036] Anomeric mixtures of 2-deoxy-2,2-difluoro-D-<br>
ribofuranose sulfonates can be readily synthesized by<br>
methods published in the prior art, such as U.S. Patent<br>
Nos. 4,526,988; 4,965,374; and 5,252,756. The entire<br>
content of each of these patents is incorporated herein<br>
as reference. The temperature of the reaction has been<br>
shown to greatly influence the formation of alpha-<br>
sulfonate over beta-sulfonate (see U.S. Patent No.<br>
5,401,861). The use of higher temperatures produces less<br>
enhancement of the alpha-sulfonate formation and,<br>
therefore, lower yields of enriched alpha-sulfonate<br>
after crystallization.<br>
[0037] This invention provides several methods of re-<br>
enhancing the alpha/beta mixture that remains after<br>
crystallization in order to recycle back the re-enhanced<br>
mixture to an alpha-suifonate enhanced product.<br>
[0038] The first method takes advantage of "the<br>
ability to solvolyze a sulforiate back to the lactol in a<br><br>
15<br>
mixture of a polar organic solvent and water. This is<br>
indicated below.<br><br>
III<br>
[0039] The resulting lactol can then readily be<br>
subjected to the sulfonation procedure to produce an<br>
alpha-sulfonate, in particular an anomeric mixture<br>
enriched in alpha-sulfonate. This cycle greatly<br>
increases the yield of enriched alpha-mesylate that can<br>
be obtained from the initial lactol. The sulfonation<br>
procedure of producing the alpha-sulfonate, in<br>
particular the anomeric mixture enriched in alpha-<br>
sulfonate, from the lactol, can be any suitable method,<br>
such as the low temperature process disclosed in U.S.<br>
Patent No. 5,401,861, the entire content of which is<br>
incorporated herein as reference.<br>
[0040] The solvolysis occurs by a SN1 mechanism under<br>
thermal conditions. A polar, higher boiling non-<br>
nucleophilic organic solvent in which water is soluble<br>
is preferred. Suitable solvents could be, but not<br>
limited to, water soluble ethers, amides, nitriles, and<br>
sulfoxides. For a better rate of reaction, a<br>
temperature of at least 100°C is preferred and a<br>
temperature range of about 100°C to about 140°C is more<br>
preferred. Complete conversion of the sulfonate can<br><br>
16<br>
occur in minutes to hours, and the lactol product can<br>
easily be recovered by addition of water and extraction<br>
into an organic solvent.<br>
[0041] In accordance with one embodiment of the<br>
present invention, the process of making the lactol of<br>
formula III from the sulfonates of formula V can be<br>
carried out as follows: a) dissolving the alpha/beta<br>
sulfonate mixture of formula V in a mixture of a water<br>
miscible solvent, water, and optionally, a weakly basic<br>
material such as carboxylates such as sodium acetate,<br>
tertary amines, buffer solutions with pH between 4-9; b)<br>
heating the mixture of a) at an elevated temperature<br>
until solvolysis is complete; c) diluting the mixture<br>
with water and extracting with an organic solvent to<br>
yield the lactol of formula (III) .<br>
[0042] The organic solvent used to extract the lactol may<br>
be any solvent not miscible in water such as toluene,<br>
methylene chloride, ethyl acetate, etc.<br>
[0043] The second method of recovering an alpha-<br>
enhanced ribofuranosyl sulfonate proceeds through the<br>
direct thermal isomerization of the alpha/beta mixture<br>
without the addition of any sulfonate salt used by the<br>
process of U.S. Patent No. 5,256,798.<br>
[0044] U.S. Patent No. 5,256,7 98 discloses that<br>
"heating a solution of 2-deoxy-2,2-difluororibofuranosyl<br>
methanesulfonate in an inert organic solvent to 130°C for<br>
extended periods of time does not effect the anomeric<br>
configuration of the anomer". Therefore, U.S. Patent<br>
5,256,7 98 proposes an anomerization process for<br>
providing an alpha-anomer enriched ribofuranosyl<br>
sulfonate by treating a beta-anomer ribofuranosyl<br><br>
17<br>
sulfonate with a sulfonate salt at an elevated<br>
temperature in an inert solvent.<br>
[0045] We have surprisingly discovered that, simply<br>
heating beta-anomer sulfonate of formula (II) that is<br>
essentially free of any solvent and in the absence of<br>
any sulfonate salt at an elevated temperature up to<br>
about 130°C readily produces anomeric isomerization. The<br>
preferred temperature range is about 90°C to about 130°C.<br>
In fact, this method can be used to prepare enhanced<br>
alpha mixtures directly from the mesylation reaction by<br>
simply working up the reaction as normal, removing the<br>
solvent, heating the residue, adding a suitable organic<br>
solvent and crystallizing the enriched alpha sulfonate.<br>
After each isolation of the enriched alpha-sulfonate,<br>
the residue can be ,recycled by simply removing the<br>
solvent, heating the residue, adding a suitable organic<br>
solvent and crystallizing the enriched alpha-sulfonate.<br>
In the context of performing this process to produce<br>
enhanced alpha mixtures, the condition of essentially<br>
free of any solvents means in the presence of a solvent<br>
in no amount that would substantially prevent the<br>
production of enhanced alpha mixtures.<br>
EXAMPLES<br>
[0046] The following examples illustrate specific<br>
aspects of the present invention and are not intended to<br>
limit the scope thereof in any aspect and should be. so<br>
construed.<br>
Example 1: Isomerization of an Anomeric Mixture, of 2-<br>
deoxy-2,2-difluoro-D-ribofuranose Mesylate<br><br>
18<br>
[0047] In a suitable flask is placed 10 grains of 2-<br>
deoxy-2,2-difluoro-D-ribofuranose mesylate with a<br>
alpha/beta ratio of 1.43. The mixture is heated without<br>
solvent for 3 hours at 120°C to effect isomerization. The<br>
mixture is cooled to 75°C and the HPLC indicated an<br>
alpha/beta ratio of approximately 2:1. To this mixture<br>
was charged 28 ml of ethyl acetate and 42 ml of heptane<br>
and 1 gram of activated carbon. The mixture was stirred<br>
1 hour at 70°C, filtered and cooled to 20°C. A seed<br>
crystal of 2-deoxy-2,2-difluoro-D-ribofuranose alpha-<br>
mesylate and the mixture was further cooled to 0C with<br>
stirring. After stirring for 2 hours, the product was<br>
collected by filtration and the alpha-mesylate was<br>
collected. The yield was 2.3 grams of material<br>
exhibiting a alpha/beta ratio of 20:1. The solvent can<br>
be removed from the filtrate and the isomerization and<br>
crystallization process repeated with similar results.<br>
Example 2: Isomerization of 2-deoxy-2,2-difluoro-D-<br>
ribofuranose beta-mesylate to an Mixture Enriched in 2-<br>
deoxy-2,2-difluoro-D-ribofuranose alpha-mesylate<br>
[0048] A mixture containing a substantial amount of<br>
2-deoxy-2,2-difluoro-D-ribofuranose beta-mesylate<br>
(alpha/beta 1:8) was heated in the absence of any<br>
solvent at 130°C for 3 hours. HPLC analysis indicated an<br>
alpha/beta ratio of 1.7:1.<br>
Example 3: Hydrolysis of Anomeric Mixture of 2-deoxy-<br>
2,2-difluoro-D-ribofuranose mesylate<br>
[0049] To a flask containing 50 grams of 2-deoxy-2,2-<br>
difluoro-D-ribofuranose mesylate anomeric mixture<br>
(alpha/beta 1:1) was added 250 ml DMF and 12 ml water.<br><br>
19<br>
The mixture was heated at reflux for 4 hours at which<br>
time analysis indicated that all the mesylate had been<br>
converted back to 2-deoxy-2,2-difluoro-D-ribofuranose.<br>
The mixture is diluted with water and extracted with<br>
ethyl acetate. The solution is washed with water and the<br>
solvent is removed. Toluene is added and distilled to<br>
produce an oil (48 grams) which can be used in a low<br>
temperature reaction (e.g., the low temperature process<br>
disclosed in U.S. Patent No. 5,401,861) to produce a 2-<br>
deoxy-2, 2-difluoro-D-ribofuranose alpha-mesylate<br>
enriched product.<br>
[0050] The present invention is not limited by the<br>
embodiments described above which are presented as<br>
examples only but can be modified in various ways within<br>
the scope of protection defined by the appended patent<br>
claims.<br><br>
20<br>
CLAIMS<br>
We claim:<br>
1.	A process for producing an alpha-anomer<br>
ribofuranosyl sulfonate of formula (I)<br><br>
I<br>
from a beta-anomer of ribofuranosyl sulfonate of<br>
formula (II)<br><br>
II<br>
comprising heating the beta-anomer that is<br>
essentially free of a solvent at an elevated<br>
temperature to convert the beta-anomer to the<br>
alpha-anomer in the absence of an effective amount<br>
of a sulfonate salt to facilitate the conversion of<br>
the beta-anomer to the alpha-anomer; wherein each Y<br>
is independently selected from hydroxyl protecting<br>
groups, and R is an alkyl, substituted alkyl, aryl,<br>
or a substituted aryl group.<br>
2.	The process of claim 1 wherein the elevated<br>
temperature is up to about 130°C.<br>
3.	The process of claim 1 wherein the elevated<br>
temperature is from about 90°C to about 130°C.<br><br>
21<br>
4.	The process of claim 1 wherein R is a lower alky or<br>
aryl group.<br>
5.	The process of claim 1 wherein R is methyl.<br>
6.	The process of claim 1 wherein R is benzoyl or<br>
substituted benzoyl.<br><br>
7.	The process of claim 1 wherein the produced alpha-<br>
anomer is present in an alpha-anomer enriched<br>
mixture, and the heated beta-anomer is present in an<br>
anomeric mixture.<br>
8.	A process of making a nucleoside of formula (IV)<br><br>
comprising:<br>
a) heating a beta-anomer of formula (II) that is<br>
essentially free of a solvent<br><br>
at an elevated temperature to convert the beta-<br>
anomer to an alpha-anomer of formula (I)<br><br>
22<br><br>
in the absence of an effective amount of a<br>
sulfonate salt to facilitate the conversion of the<br>
beta-anomer to the alpha-anomer; and<br>
b) reacting the alpha-anomer with a nucleobase<br>
derivative to prepare the nucleoside;<br>
wherein each Y is independently selected from<br>
hydroxyl protecting groups, R is an alkyl,<br>
substituted alkyl, aryl, or a substituted aryl<br>
group; and R' is a nucleobase.<br>
9. The process of claim 8 wherein R' is any of the<br>
following:<br><br>
23<br><br>
wherein R1 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof;<br>
and R2 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof.<br>
10 . The process of claim 8 wherein R' is any of the <br>
following:<br><br>
24<br><br>
wherein Z is a hydroxyl protecting group; W is an<br>
amino protecting group; R1 is selected from the<br>
group consisting of hydrogen, alkyl, halo, and<br>
derivatives thereof; and R2 is selected from the<br>
group consisting of hydrogen, alkyl, halo, and<br>
derivatives thereof.<br>
11. The process of claim 8 . wherein the nucleobase<br>
derivative is selected from the following:<br><br>
25<br><br>
wherein Z is a hydroxyl protecting group; W is an<br>
amino protecting group; R1 is selected from the<br>
group consisting of hydrogen, alkyl, halo, and<br>
derivatives thereof; and R2 is selected from the<br>
group consisting of hydrogen, alkyl, halo, and<br>
derivatives thereof.<br>
12.	The process of claim 8 wherein nucleoside is<br>
gemcitabine.<br>
13.	A process of making a lactol of formula (III)<br>
comprising the steps of:<br>
a) dissolving an anomeric mixture of formula (V) in<br>
a mixture of a polar organic solvent and water<br><br>
26<br><br>
III<br>
wherein each Y is independently selected from,<br>
hydroxyl protecting groups, and R is an alkyl,<br>
substituted alkyl, aryl, or a substituted aryl<br>
group;<br>
b)	heating the mixture at an elevated temperature<br>
to cause the reaction of solvolysis; and<br>
c)	diluting the mixture with water and extracting<br>
the lactol with a water-immiscible organic<br>
solvent.<br>
14.	The process of claim 13 wherein the<br>
elevated temperature is at least 100°C.<br>
15.	The process of claim 13 wherein the<br>
elevated temperature is from about 100°C to about<br>
140°C.<br>
16.	The process of claim 13 wherein the<br>
polar organic solvent is selected from amides,<br>
sulfoxides, nitriles, and ethers.<br>
17.	The process of claim 13 wherein the<br>
polar organic solvent is N,N-dimethylformamide.<br>
18.	The process of claim 13 wherein Y is<br>
benzoyl or substituted benzoyi and R is methyl.<br>
19.	The process of claim 13 wherein the<br>
lactol is reacted with a sulfonating reagent to<br>
produce an alpha anomer of (I)<br><br>
27<br><br>
wherein each Y is independently selected from<br>
hydroxyl protecting groups, and R is an alkyl,<br>
substituted alkyl, aryl, or a substituted aryl<br>
group.<br>
20.	The process of claim 19 wherein the<br>
produced alpha-anomer is present in an alpha-anomer<br>
enriched mixture.<br>
21.	The process of claim 19 wherein the alpha<br>
anomer of formula (I) is reacted with a nucleobase<br>
derivative to produce a nucleoside.<br>
22.	A process of making a nucleoside of<br>
formula (IV)<br><br>
wherein each Y is independently selected from<br>
hydroxyl protecting groups; R' is a nucleobase;<br>
comprising:<br>
a) dissolving an anomeric mixture of formula (V)<br>
in a mixture of polar organic solvent and water<br><br>
28<br><br>
III<br>
wherein each Y is independently selected from<br>
hydroxyl protecting groups, and R is an alkyl,<br>
substituted alkyl, aryl, or a substituted aryl<br>
group;<br>
b)	heating the mixture at an elevated temperature<br>
to cause a solvolysis reaction; and<br>
c)	diluting the mixture with water and extracting<br>
the lactol with a water-immiscible organic<br>
solvent;<br>
d)	reacting the lactol with a sulfonating reagent<br>
to produce an alpha anomer of formula (I)<br><br>
wherein each Y is independently selected from<br>
hydroxyl protecting groups, and R is an alkyl,<br>
substituted alkyl, aryl, or a substituted aryl<br>
group; and<br>
e) reacting the alpha anomer of formula (I) with a<br>
nucleoside derivative to prepare the nucleoside.<br>
23.	The process of claim 22 wherein the<br>
produced alpha-anomer of formula (I) is present in<br>
an alpha-anomer enriched mixture.<br>
24.	The process of claim 22 wherein R' is any<br>
of the following:<br><br>
29<br><br>
wherein R1 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof; and<br>
R2 is selected from the group consisting of<br>
hydrogen, alkyl, halo, and derivatives thereof.<br>
25. The process of claim 22 wherein the<br>
nucleoside is gemcitabine.<br><br><br>
A process of preparing an alpha-anomer enriched 2- deoxy-2, 2-difluoro-D-ribofunanosyl sulfonate, which is useful as an intermediate in the preparation of a beta nucleoside, such as gemcitabine, an anti-tumor agent. A beta-2-deoxy-2,2-difluoro-D-ribofunanosyl sulfonate is heated and converted to an alpha-2-deoxy-2, 2-difluoro-D- ribofunanosyl sulfonate in the absence of<br>
an effective amount of a sulfonate salt to facilitate the conversion. In addition, an anomeric mixture of an alpha-anomer and a<br>
beta-anomer of 2-deoxy-2, 2-difluoro-D-ribofunanosyl sulfonate can be dissolved in a mixture of water and a solvent and heated to<br>
produce a lactol, which may be further converted to jan alpha-anomer enriched 2-deoxy- 2, 2-difluoro-D-ribofunanosyl sulfonate.</td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1hYnN0cmFjdC5wZGY=" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1jbGFpbXMucGRm" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1jb3JyZXNwb25kZW5jZSBvdGhlcnMucGRm" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-correspondence others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1kZXNjcmlwdGlvbiBjb21wbGV0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-description complete.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1mb3JtIDEucGRm" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1mb3JtIDMucGRm" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1mb3JtIDUucGRm" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MDQ2NTEta29sbnAtMjAwNy1pbnRlcm5hdGlvbmFsIHB1YmxpY2F0aW9uLnBkZg==" target="_blank" style="word-wrap:break-word;">04651-kolnp-2007-international publication.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1BQlNUUkFDVC5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1BTUFOREVEIENMQUlNUy5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-AMANDED CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1BTUFOREVEIFBBR0VTIE9GIFNQRUNJRklDQVRJT04ucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-AMANDED PAGES OF SPECIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1BTk5FWFVSRSBUTyBGT1JNIDMucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-ANNEXURE TO FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1ERVNDUklQVElPTiAoQ09NUExFVEUpLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1GT1JNLTEucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-FORM-1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1GT1JNLTEzLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-FORM-13.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1GT1JNLTIucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-FORM-2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwNi0wOS0yMDEyKS1QRVRJVElPTiBVTkRFUiBSVUxFIDEzNy5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(06-09-2012)-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwOC0wOC0yMDEyKS1FWEFNSU5BVElPTiBSRVBPUlQgUkVQTFkgUkVDRUlWRUQucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(08-08-2012)-EXAMINATION REPORT REPLY RECEIVED.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgwOC0wOC0yMDEyKS1PVEhFUlMucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(08-08-2012)-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LSgyOC0wMi0yMDEzKS1DT1JSRVNQT05ERU5DRS5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-(28-02-2013)-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUFTU0lHTk1FTlQtMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-ASSIGNMENT-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LUFTU0lHTk1FTlQucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-ASSIGNMENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUNBTkNFTExFRCBQQUdFUy5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-CANCELLED PAGES.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LUNPUlJFU1BPTkRFTkNFIE9USEVSUyAxLjEucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUNPUlJFU1BPTkRFTkNFLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-CORRESPONDENCE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-EXAMINATION REPORT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUZPUk0gMTMucGRm" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-FORM 13.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUZPUk0gMTgtMS4xLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-FORM 18-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LUZPUk0gMy0xLjEucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-FORM 3-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdQQS0xLjEucGRm" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GPA-1.1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LUdQQS5wZGY=" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-GPA.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtQUJTVFJBQ1QucGRm" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-ABSTRACT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtQ0xBSU1TLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-CLAIMS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtREVTQ1JJUFRJT04gKENPTVBMRVRFKS5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-DESCRIPTION (COMPLETE).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtRk9STSAxLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-FORM 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtRk9STSAyLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-FORM 2.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtRk9STSAzLnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-FORM 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtRk9STSA1LnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-FORM 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtTEVUVEVSIFBBVEVOVC5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-LETTER PATENT.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUdSQU5URUQtU1BFQ0lGSUNBVElPTi1DT01QTEVURS5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-GRANTED-SPECIFICATION-COMPLETE.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUlOVEVSTkFUSU9OQUwgUFVCTElDQVRJT04ucGRm" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-INTERNATIONAL PUBLICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LUlOVEVSTkFUSU9OQUwgU0VBUkNIIFJFUE9SVCAmIE9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-INTERNATIONAL SEARCH REPORT &amp; OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LU9USEVSUy5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-OTHERS.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1LT0xOUC0yMDA3LVBDVCBQUklPUklUWSBET0NVTUVOVCBOT1RJRklDQVRJT04ucGRm" target="_blank" style="word-wrap:break-word;">4651-KOLNP-2007-PCT PRIORITY DOCUMENT NOTIFICATION.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LVBFVElUSU9OIFVOREVSIFJVTEUgMTM3LnBkZg==" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-PETITION UNDER RULE 137.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NDY1MS1rb2xucC0yMDA3LVJFUExZIFRPIEVYQU1JTkFUSU9OIFJFUE9SVC5wZGY=" target="_blank" style="word-wrap:break-word;">4651-kolnp-2007-REPLY TO EXAMINATION REPORT.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="261001-improved-control-system-for-operation-of-an-automobile-powered-by-an-electronically-controlled-engine-and-automatic-transmission-and-method-of-controlling-thereof.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="261003-membrane-assay-method.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>261002</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>4651/KOLNP/2007</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>23/2014</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>06-Jun-2014</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>30-May-2014</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>30-Nov-2007</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>SCHLOEMER GEORGE</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>NO. 1, NAN-KE 8TH ROAD, SHAN-HUA, TAINAN COUNTY 74144, TAIWAN</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>WANG LUNG-HU</td>
											<td>NO. 1, NAN-KE 8TH ROAD, SHAN-HUA, TAINAN COUNTY 74144, TAIWAN</td>
										</tr>
										<tr>
											<td>2</td>
											<td>SCHLOEMER GEORGE</td>
											<td>NO. 1, NAN-KE 8TH ROAD, SHAN-HUA,TAINAN COUNTY 74144, TAIWAN</td>
										</tr>
										<tr>
											<td>3</td>
											<td>LIU ALLEN</td>
											<td>NO. 1, NAN-KE 8TH ROAD, SHAN-HUA, TAINAN COUNTY 74144, TAIWAN</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07H 19/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/US2006/020131</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2006-05-24</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>60/687593</td>
									<td>2005-06-03</td>
								    <td>U.S.A.</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/261002-process-for-production-of-alpha-anomer-of-ribofuranosyl-sulfonate-and-production-of-nucleoside-from-the-alpha-anomer-so-produced by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:42:57 GMT -->
</html>
